Expectant Management of Hypertensive Disorders of Pregnancy and Future Cardiovascular Morbidity
- PMID: 31809423
- PMCID: PMC6923587
- DOI: 10.1097/AOG.0000000000003567
Expectant Management of Hypertensive Disorders of Pregnancy and Future Cardiovascular Morbidity
Abstract
Objective: To test the hypothesis that a longer length of time between diagnosis of hypertensive disorders of pregnancy and delivery is associated with increased risk of cardiovascular morbidity in the years after delivery.
Methods: This is a retrospective cohort study based in the New York State Inpatient Database. The first delivery for all patients from 2005 to 2014 who delivered preterm with an International Classification of Diseases, 9th Revision, Clinical Modification code for hypertensive disorders of pregnancy (excluding isolated chronic hypertension) was included. The duration between diagnosis and delivery was divided into 7 days or less or more than 7 days. The primary outcome was admission for a composite of cardiovascular disease, stroke, or death after the index delivery through December 31, 2014.
Results: There were 22,594 patients with a median follow-up period of 5.2 years: 19,750 (87.4%) were delivered within 7 days of diagnosis and 2,844 (12.6%) were delivered more than 7 days from diagnosis. The primary outcome occurred in 216 (1.1%) patients in the 0-7 days group (21 events/10,000 person-years) and 67 (2.4%) patients in the more than 7 days group (46 events/10,000 person-years), adjusted hazard ratio 1.45 (95% CI 1.09 to 1.93). The findings were robust in a number of sensitivity analyses.
Conclusions: Prolonged expectant management of preterm hypertensive disorders of pregnancy is associated with an increased risk of maternal cardiac disease in the ensuing years.
Conflict of interest statement
Financial Disclosure
Margaret A. Olsen disclosed that money has been paid to her institution from Pfizer, Merck, and Sanofi Pasteur. The other authors did not report any potential conflicts of interest.
Figures


Comment in
-
Prolongation of Pregnancy Complications and the Risk of Future Cardiovascular Disease.Obstet Gynecol. 2020 Jan;135(1):24-25. doi: 10.1097/AOG.0000000000003628. Obstet Gynecol. 2020. PMID: 31809441 No abstract available.
-
Expectant Management of Hypertensive Disorders of Pregnancy and Future Cardiovascular Morbidity.Obstet Gynecol. 2020 Mar;135(3):732. doi: 10.1097/AOG.0000000000003739. Obstet Gynecol. 2020. PMID: 32080038 No abstract available.
-
In Reply.Obstet Gynecol. 2020 Mar;135(3):732-733. doi: 10.1097/AOG.0000000000003740. Obstet Gynecol. 2020. PMID: 32080039 No abstract available.
-
Expectant Management of Hypertensive Disorders of Pregnancy and Future Cardiovascular Morbidity.Obstet Gynecol. 2020 Apr;135(4):974. doi: 10.1097/AOG.0000000000003798. Obstet Gynecol. 2020. PMID: 32217959 No abstract available.
-
In Reply.Obstet Gynecol. 2020 Apr;135(4):974. doi: 10.1097/AOG.0000000000003799. Obstet Gynecol. 2020. PMID: 32217960 No abstract available.
References
-
- Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Pina IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D’Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr., Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK. Effectiveness-based guidelines for the prevention of cardiovascular disease in women−-2011 update: a guideline from the american heart association. Circulation. 2011;123(11):1243–62. - PMC - PubMed
-
- Brown HL, Warner JJ, Gianos E, Gulati M, Hill AJ, Hollier LM, Rosen SE, Rosser ML, Wenger NK, American Heart A, the American College of O, Gynecologists. Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation. 2018;137(24):e843–e52. - PubMed
-
- Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, Howard VJ, Lichtman JH, Lisabeth LD, Pina IL, Reeves MJ, Rexrode KM, Saposnik G, Singh V, Towfighi A, Vaccarino V, Walters MR, American Heart Association Stroke C, Council on C, Stroke N, Council on Clinical C, Council on E, Prevention, Council for High Blood Pressure R. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(5):1545–88. - PMC - PubMed
-
- Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366(9499):1797–803. - PubMed
-
- Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28(1):1–19. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical